SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Tomohiro Tanaka, Noriyo Yamashiki, Yasuhiko Sugawara, Sumihito Tamura, Minoru Nakamura, Junichi Kaneko, Taku Aoki, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Norihiro Kokudo, Chronologic changes of explanted liver volume and the use of ursodeoxycholic acid in patients with end-stage primary biliary cirrhosis, Hepatology Research, 2014, 44, 5
  2. 2
    Anthony W H Chan, Ronald C K Chan, Grace L H Wong, Vincent W S Wong, Paul C L Choi, Henry L Y Chan, Ka-Fai To, Evaluation of histological staging systems for primary biliary cirrhosis: correlation with clinical and biochemical factors and significance of pathological parameters in prognostication, Histopathology, 2014, 64, 6
  3. 3
    Palak J. Trivedi, Tony Bruns, Angela Cheung, Ka-Kit Li, Clemens Kittler, Teru Kumagi, Husnain Shah, Christopher Corbett, Nadya Al-Harthy, Unsal Acarsu, Catalina Coltescu, Dhiraj Tripathi, Andreas Stallmach, James Neuberger, Harry L.A. Janssen, Gideon M. Hirschfield, Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response, Journal of Hepatology, 2014,

    CrossRef

  4. 4
    Avegail Flores, Marlyn J. Mayo, Primary biliary cirrhosis in 2014, Current Opinion in Gastroenterology, 2014, 30, 3, 245

    CrossRef

  5. You have free access to this content5
    Albert Parés, Treatment of primary biliary cirrhosis: Is there more to offer than ursodeoxycholic acid?, Clinical Liver Disease, 2014, 3, 2
  6. 6
    Carlo Selmi, Ian R. Mackay, M. Eric Gershwin, The Autoimmune Diseases, 2014,

    CrossRef